Website Launch: SynDevRx
June 25, 2017
As a young company in the crowded pharma and oncology space, SynDevRx needed to find a way to quickly define their value offering. Metropolis helped them achieve that with a fresh design, custom diagrams, and clear copywriting from The Hired Pens. The new website design is fully content-managed and responsive for any screen size.
One of the cool technical features of the site is the interactive cancer treatment diagram on the home page. The whole diagram is content-manageable. To update it, the client just needs to add a new oncology type, enter the text, upload the new bar chart, and assign a set of coordinates for the colored dot.
Metabo-oncology — which focuses on the link between cancer and metabolic dysfunction — is poised to spark a paradigm shift in cancer treatment. SynDevRx is the leader in this emerging field. Their lead compound, SDX-7320 is a methionine aminopeptidase type II (MetAP2) inhibitor that proposes to both treat the tumor directly and correct the underlying metabolic dysfunction — sort of a one-two punch to cancer.